Sanofi SA (NASDAQ:SNY)
| 46.95 BATS BZX Real-Time Price As of 10:02am ET |  -0.31 / -0.66%Today’s Change | 37.62 Today|||52-Week Range 51.84 | -6.47% Year-to-Date |
Latest SNY News | Press Releases
| Sanofi to Sell Its 20.6% Stake in Regeneron, but Keep Their Collaboration Intact May 26 / MotleyFool.com - Paid Partner Content | Should You Buy MyoKardia Stock After This Week’s 96% Gain? May 16 / MotleyFool.com - Paid Partner Content |
| Does Novavax Have What It Takes to Win the COVID-19 Vaccine Race? May 24 / MotleyFool.com - Paid Partner Content | Where Will Novavax Be in 1 Year? May 16 / MotleyFool.com - Paid Partner Content |
| Better Buy: GlaxoSmithKline vs. Pfizer May 20 / MotleyFool.com - Paid Partner Content | Trump Taps Former GlaxoSmithKline Exec For 'Warp Speed' COVID-19 Vaccine Initiative May 15 / MotleyFool.com - Paid Partner Content |
| Is Buying a Basket Loaded With Every Coronavirus Vaccine Stock a Smart Strategy? May 17 / MotleyFool.com - Paid Partner Content | France piles pressure on Sanofi over coronavirus vaccine plans May 15 / CNN.com - Paid Partner Content |
| Moderna and Novavax are Making Strides in Advancing Novel Coronavirus Vaccine Research May 16 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 47.26 |
| Today’s open | 47.21 |
| Day’s range | 46.78 - 47.23 |
| Volume | 17,716 |
| Average volume (3 months) | 2,454,147 |
| Market cap | $118.6B |
Data as of 10:05am ET, 05/27/2020
Growth & Valuation
| Earnings growth (last year) | -38.50% |
| Earnings growth (this year) | +3.50% |
| Earnings growth (next 5 years) | +7.00% |
| Revenue growth (last year) | -0.55% |
| P/E ratio | 37.0 |
| Price/Sales | 3.10 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | -1.11 | -1.75% |
| GSKGlaxoSmithKline | -0.13 | -0.32% |
| BMYBristol-Myers Squibb | -0.51 | -0.85% |
| AZNAstraZeneca | -1.59 | -2.99% |
Data as of 10:05am ET, 05/27/2020
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | $0.71 |
| Annual revenue (last year) | $40.4B |
| Annual profit (last year) | $3.1B |
| Net profit margin | 8.05% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
Forecasts
